In an insight-packed webinar and panel discussion hosted by BSMA, industry leaders Dan Bell (Chief Strategy Officer, Marken), Dr. Rohin Iyer (Senior Director, Cell and Gene Operations, Marken), and Dr. Priya Baraniak (Chief Commercial & Development Officer, Pluristyx) explored the critical challenges reshaping advanced therapy logistics – from geopolitical volatility and rising tariffs to raw material shortages and manufacturing disruptions.

As the global pipeline of cell and gene therapies accelerates, so does the urgency for scalable, secure delivery. The discussion spotlighted transformative solutions including AI-powered analytics, decentralized manufacturing, “factory-in-a-box” technologies, and strategic supply chain diversification. Dan Bell guided the thought-provoking session with probing questions like, “How are you minimizing the impact of tariffs on manufacturing and logistics?” and “Is the industry ready for therapies on demand?”.

With deep regulatory expertise and global reach, Marken is redefining precision logistics in a rapidly evolving market. Watch the full webinar to gain expert strategies for future-proofing your advanced therapy supply chain.